SUSQUEHANNA INTERNATIONAL GROUP, LLP - MERRIMACK PHARMACEUTICALS IN ownership

MERRIMACK PHARMACEUTICALS IN's ticker is MACK and the CUSIP is 590328209. A total of 43 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q2 2022. The put-call ratio across all filers is 2.37 and the average weighting 0.3%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of MERRIMACK PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$4,014,068
+123.5%
325,553
+123.0%
0.00%
Q2 2023$1,795,985
-59.0%
146,015
-59.0%
0.00%
-100.0%
Q1 2023$4,377,637
-20.4%
356,195
-25.8%
0.00%
-50.0%
Q4 2022$5,497,775
+1899.2%
479,736
+555.2%
0.00%
Q3 2022$275,000
-31.1%
73,218
+9.4%
0.00%
Q2 2022$399,000
-68.4%
66,947
-66.5%
0.00%
Q1 2022$1,263,000
-47.8%
199,630
-67.7%
0.00%
Q4 2021$2,420,000
+343.2%
618,398
+447.3%
0.00%
Q3 2021$546,000
+23.8%
113,000
+63.5%
0.00%
Q2 2021$441,000
-67.2%
69,122
-67.7%
0.00%
Q1 2021$1,345,000
-77.3%
214,129
-75.1%
0.00%
Q4 2020$5,916,000
+815.8%
858,824
+432.2%
0.00%
Q3 2020$646,000
+371.5%
161,383
+293.2%
0.00%
Q2 2020$137,000
-37.2%
41,045
-59.5%
0.00%
Q1 2020$218,000
-68.4%
101,303
-53.6%
0.00%
Q4 2019$689,000
+138.4%
218,377
+239.6%
0.00%
Q3 2019$289,000
-30.7%
64,300
-6.8%
0.00%
Q2 2019$417,000
+279.1%
69,000
+336.7%
0.00%
Q1 2019$110,000
-63.6%
15,800
-72.1%
0.00%
Q3 2018$302,000
-41.6%
56,600
-46.2%
0.00%
Q2 2018$517,000
-17.3%
105,163
+35.3%
0.00%
Q1 2018$625,000
+15.3%
77,700
+46.8%
0.00%
Q4 2017$542,000
+2.7%
52,940
+45.8%
0.00%
Q3 2017$528,00036,3000.00%
Other shareholders
MERRIMACK PHARMACEUTICALS IN shareholders Q2 2022
NameSharesValueWeighting ↓
Western Standard LLC 1,894,013$23,353,18021.09%
Newtyn Management, LLC 1,873,694$23,102,6475.70%
Sio Capital Management, LLC 288,466$3,556,7861.10%
Madison Avenue Partners, LP 553,085$6,819,5380.97%
WITTENBERG INVESTMENT MANAGEMENT, INC. 209,739$2,5860.95%
Indaba Capital Management, L.P. 136,802$1,686,7690.50%
Sepio Capital, LP 306,680$3,781,3640.33%
Yakira Capital Management, Inc. 54,118$667,2750.18%
Centiva Capital, LP 187,803$2,315,6110.05%
FIFTH LANE CAPITAL, LP 10,929$134,4270.05%
View complete list of MERRIMACK PHARMACEUTICALS IN shareholders